These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 38895505)

  • 1. Protective Activities of Growth Hormone-Releasing Hormone Antagonists against Toxin-Induced Endothelial Injury.
    Fakir S; Barabutis N
    Endocrines; 2024 Mar; 5(1):116-123. PubMed ID: 38895505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth hormone-releasing hormone antagonists protect against hydrochloric acid-induced endothelial injury in vitro.
    Barabutis N; Kubra KT; Akhter MS
    Environ Toxicol Pharmacol; 2023 Apr; 99():104113. PubMed ID: 36940786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone-releasing hormone antagonists counteract interferon-γ - induced barrier dysfunction in bovine and human endothelial cells.
    Fakir S; Barabutis N
    Cytokine; 2024 Jan; 173():156416. PubMed ID: 37952313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effects of GHRH antagonists against hydrogen peroxide-induced lung endothelial barrier disruption.
    Akhter MS; Kubra KT; Barabutis N
    Endocrine; 2023 Mar; 79(3):587-592. PubMed ID: 36261700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of reactive oxygen species in endothelial cells by an antagonist of growth hormone-releasing hormone.
    Akhter MS; Barabutis N
    J Biochem Mol Toxicol; 2021 Oct; 35(10):e22879. PubMed ID: 34369038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth hormone-releasing hormone antagonists counteract hydrogen peroxide - induced paracellular hyperpermeability in endothelial cells.
    Barabutis N; Siejka A; Akhter MS
    Growth Horm IGF Res; 2023; 69-70():101534. PubMed ID: 37210756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth Hormone-Releasing Hormone Antagonist JV-1-36 Suppresses Reactive Oxygen Species Generation in A549 Lung Cancer Cells.
    Kubra KT; Akhter MS; Apperley K; Barabutis N
    Endocrines; 2022 Dec; 3(4):813-820. PubMed ID: 36540765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effects of growth hormone - releasing hormone antagonists in the lungs of septic mice.
    Fakir S; Kubra KT; Akhter MS; Uddin MA; Barabutis N
    Cell Signal; 2024 Sep; 121():111260. PubMed ID: 38871041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An antagonist of growth hormone-releasing hormone protects against LPS-induced increase of bronchoalveolar lavage fluid protein concentration.
    Akhter MS; Kubra KT; Uddin MA; Jois S; Barabutis N
    Inflamm Res; 2022 Feb; 71(2):183-185. PubMed ID: 34993559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antagonistic actions of analogs related to growth hormone-releasing hormone (GHRH) on receptors for GHRH and vasoactive intestinal peptide on rat pituitary and pineal cells in vitro.
    Rekasi Z; Varga JL; Schally AV; Halmos G; Groot K; Czompoly T
    Proc Natl Acad Sci U S A; 2000 Feb; 97(3):1218-23. PubMed ID: 10655511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of the unfolded protein response in the protective effects of growth hormone releasing hormone antagonists in the lungs.
    Akhter MS; Uddin MA; Schally AV; Kubra KT; Barabutis N
    J Cell Commun Signal; 2021 Mar; 15(1):125-129. PubMed ID: 33185812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antagonists of growth hormone-releasing hormone cross the blood-brain barrier: a potential applicability to treatment of brain tumors.
    Jaeger LB; Banks WA; Varga JL; Schally AV
    Proc Natl Acad Sci U S A; 2005 Aug; 102(35):12495-500. PubMed ID: 16118272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effect of Growth Hormone-Releasing Hormone agonist in bacterial toxin-induced pulmonary barrier dysfunction.
    Czikora I; Sridhar S; Gorshkov B; Alieva IB; Kasa A; Gonzales J; Potapenko O; Umapathy NS; Pillich H; Rick FG; Block NL; Verin AD; Chakraborty T; Matthay MA; Schally AV; Lucas R
    Front Physiol; 2014; 5():259. PubMed ID: 25076911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipopeptide antagonists of growth hormone-releasing hormone with improved antitumor activities.
    Zarandi M; Varga JL; Schally AV; Horvath JE; Toller GL; Kovacs M; Letsch M; Groot K; Armatis P; Halmos G
    Proc Natl Acad Sci U S A; 2006 Mar; 103(12):4610-5. PubMed ID: 16537407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effects of GHRH antagonists on human GH-secreting adenoma tissue.
    Szalontay L; Benveniste RJ; Schally AV; Vidaurre I; Nadji M; Zarandi M; Block NL; Kovacs M
    Neuroendocrinology; 2012; 96(1):81-8. PubMed ID: 22377963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antagonists of growth hormone-releasing hormone and vasoactive intestinal peptide inhibit tumor proliferation by different mechanisms: evidence from in vitro studies on human prostatic and pancreatic cancers.
    Rekasi Z; Varga JL; Schally AV; Halmos G; Armatis P; Groot K; Czompoly T
    Endocrinology; 2000 Jun; 141(6):2120-8. PubMed ID: 10830299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of proliferation of PC-3 human prostate cancer by antagonists of growth hormone-releasing hormone: lack of correlation with the levels of serum IGF-I and expression of tumoral IGF-II and vascular endothelial growth factor.
    Plonowski A; Schally AV; Letsch M; Krupa M; Hebert F; Busto R; Groot K; Varga JL
    Prostate; 2002 Aug; 52(3):173-82. PubMed ID: 12111694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone-releasing hormone antagonist MIA-602 inhibits inflammation induced by SARS-CoV-2 spike protein and bacterial lipopolysaccharide synergism in macrophages and human peripheral blood mononuclear cells.
    Granato G; Gesmundo I; Pedrolli F; Kasarla R; Begani L; Banfi D; Bruno S; Lopatina T; Brizzi MF; Cai R; Sha W; Ghigo E; Schally AV; Granata R
    Front Immunol; 2023; 14():1231363. PubMed ID: 37649486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effects of antagonistic analogs of GHRH on GH3 pituitary cells overexpressing the human GHRH receptor.
    Kovacs M; Schally AV; Lee EJ; Busto R; Armatis P; Groot K; Varga JL
    J Endocrinol; 2002 Nov; 175(2):425-34. PubMed ID: 12429040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of proliferation, VEGF secretion of human neuroendocrine tumor cell line NCI-H727 by an antagonist of growth hormone-releasing hormone (GH-RH) in vitro.
    Sacewicz M; Lawnicka H; Siejka A; Stepień T; Krupiński R; Komorowski J; Stepień H
    Cancer Lett; 2008 Sep; 268(1):120-8. PubMed ID: 18486324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.